Evotec SE Reports H1 2025 Financials and Updates
Ticker: EVOTF · Form: 6-K · Filed: Aug 13, 2025 · CIK: 1412558
| Field | Detail |
|---|---|
| Company | Evotec Se (EVOTF) |
| Form Type | 6-K |
| Filed Date | Aug 13, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, business-update, sec-filing
TL;DR
Evotec dropped H1 2025 results on 8/13 - check it out.
AI Summary
Evotec SE announced its financial results and business updates for the first six months of 2025 on August 13, 2025. The company is a foreign private issuer filing a Form 6-K report with the SEC.
Why It Matters
This filing provides investors with a mid-year update on Evotec's financial performance and strategic developments, crucial for assessing the company's trajectory.
Risk Assessment
Risk Level: low — This is a routine financial reporting filing (6-K) and does not contain new material events or significant financial changes.
Key Players & Entities
- Evotec SE (company) — Registrant
- August 13, 2025 (date) — Date of press release and filing
- 001-34041 (other) — SEC File Number
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is filed by Evotec SE to report its financial results and business updates for the first six months of 2025, as announced in a press release on August 13, 2025.
When did Evotec SE announce its H1 2025 financial results?
Evotec SE announced its financial results and business updates for the first six months of 2025 on August 13, 2025.
What is Evotec SE's SEC file number?
Evotec SE's SEC file number is 001-34041.
Is Evotec SE filing an annual report on Form 20-F or 40-F?
The filing indicates that the registrant files annual reports under cover of Form 20-F.
What is the principal executive office address of Evotec SE?
The principal executive offices of Evotec SE are located at Essener Bogen 7, 22419 Hamburg, Germany.
Filing Stats: 219 words · 1 min read · ~1 pages · Grade level 16.7 · Accepted 2025-08-13 07:01:41
Filing Documents
- tm2523375d1_6k.htm (6-K) — 10KB
- tm2523375d1_ex99-1.htm (EX-99.1) — 673KB
- tm2523375d1_ex99-1img01.jpg (GRAPHIC) — 95KB
- tm2523375d1_ex99-1img02.jpg (GRAPHIC) — 2KB
- tm2523375d1_ex99-1img04.jpg (GRAPHIC) — 150KB
- 0001104659-25-077175.txt ( ) — 1025KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August, 2025 COMMISSION FILE NUMBER 001-34041 Evotec SE (Translation of registrant’s name into English) Essener Bogen 7 22419 Hamburg Germany Tel: +49 40 560810 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F: Form 20-F Form 40-F Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): On August 13, 2025, Evotec SE (the “Company”) issued a press release announcing the Company’s financial results and business updates for the first six months of 2025 attached hereto as Exhibit 99.1. EXHIBIT INDEX Exhibit Description of Exhibit 99.1 Evotec SE reports H1 2025 results: Strong progress on strategy execution SIGNATURE Pursuant to the requirements, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Evotec SE By: /s/ Paul Hitchin Name: Paul Hitchin Title: Chief Financial Officer Date: August 13, 2025